Breast Lesion Localization Methods Market Report 2026

The breast lesion localization methods market size has grown rapidly in recent years. It will grow from $1.67 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing breast cancer screening rates, adoption of wire localization techniques, expansion of breast-conserving surgeries, improved imaging accessibility, growth in hospital-based oncology services.

The breast lesion localization methods market size is expected to see rapid growth in the next few years. It will grow to $2.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing shift toward wire-free localization systems, rising demand for outpatient breast procedures, expansion of precision-guided surgical technologies, growing investments in oncology imaging, increasing focus on patient comfort and workflow efficiency. Major trends in the forecast period include increasing adoption of wire-free localization techniques, rising use of magnetic and radiofrequency seed localization, growing preference for image-guided localization methods, expansion of minimally invasive breast procedures, enhanced focus on surgical accuracy and tissue preservation.

The rising incidence of breast cancer is expected to drive the growth of the breast lesion localization methods market going forward. Breast cancer is a disease in which breast cells grow uncontrollably, forming a tumor that can often be detected via X-ray or felt as a lump. The increase in breast cancer cases is fueled by longer life expectancy, as aging is a major risk factor for tumor development. Breast lesion localization methods support breast cancer treatment by enabling precise identification and marking of abnormal tissue, allowing surgeons to accurately remove tumors while preserving healthy breast tissue. For instance, in 2025, according to Cancer Australia, an Australia-based government agency, approximately 20,336 new breast cancer cases are expected to be diagnosed, accounting for 12% of all new cancer cases, while an estimated 3,353 breast cancer-related deaths are projected, representing 6.3% of all cancer deaths. Therefore, the rising incidence of breast cancer is driving the growth of the breast lesion localization methods market.

Major companies operating in the breast lesion localization market are focusing on innovating wire-free surgical guidance technologies, such as next-generation wire-free breast lesion localization, to enhance tumor targeting and reduce re-excision rates. Next-generation wire-free breast lesion localization refers to advanced, non-radioactive systems that use multi-reflector guidance to help surgeons accurately locate lesions during breast-conserving surgery. For instance, in February 2023, Merit Medical Systems Inc., a US-based medical device company, received FDA Breakthrough Device Designation for the SCOUT MD Surgical Guidance System, which includes a small implantable reflector, a handheld detection probe, and integrated software to provide real-time intraoperative feedback for precise excision of non-palpable breast lesions. The system works by emitting infrared signals from the implanted reflector that guide surgeons to the lesion and features wireless marker placement, compatibility with standard breast-conserving procedures, and real-time localization. Its applications include the localization of non-palpable breast cancers, benign lesions requiring excision, and re-excision cases, offering benefits such as reduced patient discomfort, streamlined surgical workflow, decreased reliance on radiology scheduling, and improved surgical accuracy and outcomes.

In July 2024, Hologic, Inc., a US-based medical technology company, acquired Endomagnetics Ltd. for an undisclosed amount. Through this acquisition, Hologic, Inc., aims to expand its portfolio of breast cancer surgery solutions, strengthen its position in the breast health market, and provide more comprehensive, radiation-free options for tumor localization and lymphatic mapping. Endomagnetics Ltd. is a UK-based medical device company that develops magnetic markers and guidance systems for breast lesion localization surgery.

Major companies operating in the breast lesion localization methods market are Becton, Dickinson and Company, Hologic Inc., Halma Plc, Cook Medical LLC, Merit Medical Systems Inc., Argon Medical Devices Inc., Eckert & Ziegler AG, Theragenics Corporation, SOMATEX Medical Technologies GmbH, BPB Medica S.r.l., Devicor Medical Products Inc., Cianna Medical Inc., Mermaid Medical A/S, Ranfac Corporation, Sirius Medical B.V., MOLLI Surgical Inc., IsoAid LLC, STERYLAB S.r.l., MDL S.r.l., Biomedical Srl.

North America was the largest region in the breast lesion localization methods market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast lesion localization methods market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast lesion localization methods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the breast lesion localization methods market by increasing costs of imported localization devices, imaging accessories, radioactive seeds, magnetic markers, and navigation systems used in surgical settings. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces higher costs for advanced localization technologies. These tariffs are increasing procedural costs and slowing adoption of next-generation systems. However, they are also promoting local manufacturing, regional supplier partnerships, and innovation in cost-effective localization solutions.

The breast lesion localization methods market research report is one of a series of new reports that provides breast lesion localization methods market statistics, including breast lesion localization methods industry global market size, regional shares, competitors with a breast lesion localization methods market share, detailed breast lesion localization methods market segments, market trends and opportunities, and any further data you may need to thrive in the breast lesion localization methods industry. This breast lesion localization methods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Breast lesion localization methods are medical techniques used to accurately identify the position of abnormal tissue within the breast prior to clinical procedures. These methods assist healthcare professionals in targeting the specific area of concern while minimizing damage to surrounding healthy tissue.

The main types of breast lesion localization methods include wire localization, radioactive seed localization, magnetic seed localization, ultrasound-guided localization, and needle localization. Wire localization is a traditional approach used to mark the location of a breast lesion before surgery. These methods serve multiple purposes, such as tumor identification and sentinel lymph node detection, and utilize various technologies, including radioactive, magnetic, radiofrequency, and others. They are applied in procedures such as breast biopsy, breast-conserving surgery, neoadjuvant therapy, and more, serving end users including hospitals, ambulatory surgical centers, specialty clinics, and academic and research institutes.

The breast lesion localization methods market consists of revenues earned by entities by providing services such as imaging guided biopsy services, stereotactic core biopsy, and dynamic angiothermography. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast lesion localization methods market also includes sales of localization wires, magnetic markers, radar reflectors, and related imaging guidance systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.